← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2005Last known activity
Feb 1, 2025
Timeline
1980s
- Jan 1, 1982
Minneapolis Heart Institute— Founded
Drugs by trial phase (12 distinct, 11 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT06804980Lead sponsorPhase 4Feb 1, 2025
- NCT05305911Lead sponsorPhase 2Aug 3, 2022
- NCT05305911Overall official - principal investigatorPhase 2Aug 3, 2022
- NCT05065073Overall official - principal investigatorPhase 4Sep 30, 2021
- NCT05065073Lead sponsorPhase 4Sep 30, 2021
- NCT03889314Overall official - principal investigatorPhase 4Apr 26, 2019
- NCT03889314Lead sponsorPhase 4Apr 26, 2019
- NCT03542110Lead sponsorPhase 4Aug 31, 2018
- NCT03542110Study chairPhase 4Aug 31, 2018
- NCT00787059Overall official - principal investigatorPhase 1/Phase 2Jul 1, 2010
- NCT01020968Overall official - principal investigatorPhase 2Dec 1, 2009
- NCT00893984Lead sponsorPhase 4May 1, 2009
- NCT00893984Overall official - principal investigatorPhase 4May 1, 2009
- NCT00807586Lead sponsorPhase 4Dec 1, 2008
- NCT00807586Overall official - principal investigatorPhase 4Dec 1, 2008
Details
- Founded
- Minneapolis, MN, US Jan 1, 1982
- Last known activity
- Feb 1, 2025